CIK 0001618835
- Non-accelerated filer
- Smaller reporting company
Evofem Biosciences, Inc.
Sign in to watch- Ticker
- EVFM
- Exchange
- OTC
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 208527075
- Phone
- +1 858-550-1900
- Business address
- 12400 HIGH BLUFF DRIVE, SUITE 600, SAN DIEGO, CA, 92130
- Former names
- Neothetics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-11-21 | PELLETIER SAUNDRA L Chief Executive Officer | Sale | −10,000 | $6.01 | $60K | 414,676 |
| 2019-11-21 | File Justin J. Chief Financial Officer | Sale | −4,900 | $6.00 | $29K | 202,353 |
| 2019-11-20 | File Justin J. Chief Financial Officer | Sale | −100 | $6.00 | $600 | 207,253 |
| 2019-05-21 | Kamdar Kim P. Director | Sale | −655 | $5.07 | $3K | 0 |
| 2015-12-30 | Alta Partners VIII, L.P. Former 10% Owner | Sale | −250,000 | $1.44 | $360K | 1,339,776 |
| 2015-12-29 | Alta Partners VIII, L.P. Former 10% Owner | Sale | −493,654 | $1.53 | $755K | 1,589,776 |
| 2015-12-28 | Alta Partners VIII, L.P. Former 10% Owner | Sale | −54,333 | $1.59 | $86K | 2,083,430 |
| 2015-12-17 | Locke Kenneth W Chief Scientific Officer | Sale | −598 | $1.26 | $753 | 0 |
| 2015-12-17 | Knudson Susan A. Chief Financial Officer | Sale | −1,005 | $1.26 | $1K | 0 |
| 2015-12-15 | Alta Partners VIII, L.P. 10% owner | Sale | −529,261 | $1.44 | $762K | 2,137,763 |
| 2015-11-18 | Locke Kenneth W Chief Scientific Officer | Sale | −6,098 | $8.30 | $51K | 293 |
| 2015-09-18 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Sale | −1,000 | $12.20 | $12K | 10,848 |
| 2015-09-01 | Knudson Susan A. Chief Financial Officer | Sale | −3,000 | $11.33 | $34K | 492 |
| 2015-08-07 | Kemmerer Christopher VP, Pharma Dev & Manufacturing | Sale | −1,000 | $12.88 | $13K | 10,848 |
| 2014-11-25 | JANNEY DANIEL Director | Sale | −57,143 | $14.00 | $800K | 2,538,114 |
| 2014-11-25 | JANNEY DANIEL Director | Sale | −70,714 | $14.00 | $990K | 2,583,325 |
| 2014-11-25 | JANNEY DANIEL Director | Sale | −21,429 | $14.00 | $300K | 2,597,024 |
Page 2 of 2 · 37 trades